UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)

Annals of oncology, 2018-10, Vol.29, p.viii86-viii86

2018

Volltextzugriff (PDF)

Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer

Journal of human nutrition and dietetics, 2015-06, Vol.28 (3), p.272-282

2015

Volltextzugriff (PDF)

A network approach to developing immuno-oncology combinations in Canada

Current oncology (Toronto), 2019-04, Vol.26 (2), p.73-79

2019

Volltextzugriff (PDF)

288TiPA randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

287TiPNeoadjuvant HER2-targeted therapy with or without immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Race and Sex Differences in College Student Physical Activity Correlates

American journal of health behavior, 2009-01, Vol.33 (1), p.80-90

2009

Volltextzugriff (PDF)

271TiPPreoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

LBA8_PRKEYNOTE-522: Phase III study of pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

ARE HOUSEHOLD FACTORS PUTTING IMMIGRANT HISPANIC CHILDREN AT RISK OF BECOMING OVERWEIGHT: A COMMUNITY-BASED STUDY IN EASTERN NORTH CAROLINA

Journal of community health, 2004-10, Vol.29 (5), p.387-404

2004

Volltextzugriff (PDF)

289TiPALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early stage triple negative breast cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Learned preference and aversion for complete and isoleucine-devoid diets in rats

Physiology & behavior, 1993-03, Vol.53 (3), p.485-494

1993

Volltextzugriff (PDF)

The Role of Palatability in the Food Intake Response of Rats Fed High-Protein Diets

Appetite, 1993-06, Vol.20 (3), p.181-196

1993

Volltextzugriff (PDF)

Learned preference for the limiting amino acid in rats fed a threonine-deficient diet

Physiology & behavior, 1992-05, Vol.51 (5), p.909-914

1992

Volltextzugriff (PDF)

Abstract OT3-04-02: Neoadjuvant Her2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT3-04-02-OT3-04-02

2019

Volltextzugriff (PDF)

Abstract OT2-06-05: A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT2-06-05-OT2-06-05

2019

Volltextzugriff (PDF)

Attitudes of Registered Dietitians toward Personal Overweight and Overweight Clients

Journal of the American Dietetic Association, 1997, Vol.97 (1), p.63-66

1997

Volltextzugriff (PDF)

Abstract P2-09-07: Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P2-P2-09-07

2019

Volltextzugriff (PDF)

Dietetics Majors' Weight-Reduction Beliefs, Behaviors, and Information Sources

Journal of American college health, 2001-01, Vol.49 (4), p.175-181

2001

Volltextzugriff (PDF)

Abstract P6-10-05: A pilot study of radiation (RT) and CTLA4-mediated checkpoint blockade with tremelimumab for the treatment of breast cancer brain metastases (BCBM)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-10-05

2017

Volltextzugriff (PDF)

Abstract P2-09-03: Updated efficacy of first or second-line pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC) and correlations with baseline lymphocyte and naïve CD4+ T-cell count

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P2-P2-09-03

2019

Volltextzugriff (PDF)

Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC)

Journal of clinical oncology, 2011-09, Vol.29 (27_suppl), p.3-3

2011

Volltextzugriff (PDF)

A population-based study of trastuzumab-mediated cardiotoxicity among early stage breast cancer patients treated with adjuvant trastuzumab

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10640-10640

2006

Volltextzugriff (PDF)

Use of adjuvant trastuzumab with chemotherapy in women with small, node-negative, HER2-positive breast cancers

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.615-615

2010

Volltextzugriff (PDF)

Abstract OT1-01-05: Phase 1b/2 study of intratumoral Ad-RTS-hIL-12 + veledimex in patients with chemotherapy-responsive locally advanced or metastatic breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.OT1-01-05-OT1-01-05

2016

Volltextzugriff (PDF)

Phase IB randomized, double-blinded, placebo-controlled, dose-escalation study of polyphenon E in women with a history of hormone receptor-negative breast cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS142-TPS142

2010

Volltextzugriff (PDF)

1 – 25 von 696

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(635)
Mit Volltextzugriff
(588)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(452)
Life Sciences & Biomedicine
(317)
Humans
(244)
Female
(175)
Male
(171)
Biological And Medical Sciences
(128)
Physical Sciences
(124)
Middle Aged
(111)
Adult
(109)
Astronomy & Astrophysics
(97)
Medical Sciences
(93)
General & Internal Medicine
(73)
Aged
(72)
Neurosciences & Neurology
(55)
Animals
(54)
Prospective Studies
(44)
Fundamental And Applied Biological Sciences. Psychology
(43)
Clinical Neurology
(42)
Surgery
(41)
Medicine, General & Internal
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)

Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer

A network approach to developing immuno-oncology combinations in Canada

288TiPA randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy

287TiPNeoadjuvant HER2-targeted therapy with or without immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial

Race and Sex Differences in College Student Physical Activity Correlates

271TiPPreoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)

LBA8_PRKEYNOTE-522: Phase III study of pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC)

ARE HOUSEHOLD FACTORS PUTTING IMMIGRANT HISPANIC CHILDREN AT RISK OF BECOMING OVERWEIGHT: A COMMUNITY-BASED STUDY IN EASTERN NORTH CAROLINA

289TiPALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early stage triple negative breast cancer

Learned preference and aversion for complete and isoleucine-devoid diets in rats

The Role of Palatability in the Food Intake Response of Rats Fed High-Protein Diets

Learned preference for the limiting amino acid in rats fed a threonine-deficient diet

Abstract OT3-04-02: Neoadjuvant Her2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial

Abstract OT2-06-05: A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy

Attitudes of Registered Dietitians toward Personal Overweight and Overweight Clients

Abstract P2-09-07: Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)

Dietetics Majors' Weight-Reduction Beliefs, Behaviors, and Information Sources

Abstract P6-10-05: A pilot study of radiation (RT) and CTLA4-mediated checkpoint blockade with tremelimumab for the treatment of breast cancer brain metastases (BCBM)

Abstract P2-09-03: Updated efficacy of first or second-line pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC) and correlations with baseline lymphocyte and naïve CD4+ T-cell count

Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC)

A population-based study of trastuzumab-mediated cardiotoxicity among early stage breast cancer patients treated with adjuvant trastuzumab

Use of adjuvant trastuzumab with chemotherapy in women with small, node-negative, HER2-positive breast cancers

Abstract OT1-01-05: Phase 1b/2 study of intratumoral Ad-RTS-hIL-12 + veledimex in patients with chemotherapy-responsive locally advanced or metastatic breast cancer

Phase IB randomized, double-blinded, placebo-controlled, dose-escalation study of polyphenon E in women with a history of hormone receptor-negative breast cancer

Suchergebnisse filtern